At the Brain Tumor Microenvironment lab, led by Dr. Wajd Al-Holou, we work at the intersection of spatial biology, genetics, cutting-edge therapeutics, and patient care. We are committed to identifying new treatments to improve the survival and outcomes of patients with brain tumors. In the lab, we utilize state-of-the-art genetic technology with advanced laboratory modeling to push the boundaries of this field and define new vulnerabilities in the microenvironment of brain cancers, and develop new precision medicine targeted therapies.